Plus: UnitedHealth collected billions in questionable Medicare payments, federal watchdog finds
Justin Sullivan/Getty Images Drinking is cheaper than it's been in decades. Lobbyists are fighting to keep it that way At virtually every turn — including in Nebraska, Colorado, Oregon and New Mexico — efforts to raise taxes on alcoholic beverages have been thwarted by the alcohol industry, a vast and powerful coalition of corporate conglomerates, mom-and-pop producers, retail stores, hospitality workers, trade associations and their lobbyists. Read more. By Isabella Cueto
|
|
-jpeg.jpeg?width=1252&height=704&upscale=true&name=AdobeStock_188814004-1600x900%20(1)-jpeg.jpeg)
Adobe Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies Scientifically, Pfizer's gene therapy did what it was supposed to do — yet the participants didn't benefit at all. The company has discontinued development of its Duchenne therapy, but these perplexing results still pose a major problem for the FDA. Read more. By Jason Mast and Adam Feuerstein
Patrick Sison/AP For the behemoth UnitedHealth, a new threat to Medicare profits For the nation's largest health insurer, the evidence of abuse was stunning and unmistakable: UnitedHealth Group reaped billions from the federal Medicare program by diagnosing patients with serious chronic illnesses, and then delivering no follow-up care. A new federal report contradicts a core claim of UnitedHealth's public messaging about its principal Medicare business strategy — and could usher in further investigations and restrictions that clamp down on its primary ways of making money. Read more. By Tara Bannow and Casey Ross In case you missed it... |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2024, All Rights Reserved. | |
|
No comments